Can Fite Net Worth
Can Fite Net Worth Breakdown | CANF |
Can Fite Net Worth Analysis
Can Fite's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Can Fite's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Can Fite's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Can Fite's net worth analysis. One common approach is to calculate Can Fite's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Can Fite's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Can Fite's net worth. This approach calculates the present value of Can Fite's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Can Fite's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Can Fite's net worth. This involves comparing Can Fite's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Can Fite's net worth relative to its peers.
Enterprise Value |
|
To determine if Can Fite is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Can Fite's net worth research are outlined below:
| Can Fite Biopharma generated a negative expected return over the last 90 days | |
| Can Fite Biopharma has high historical volatility and very poor performance | |
| Can Fite Biopharma may become a speculative penny stock | |
| The company reported the previous year's revenue of 743 K. Net Loss for the year was (7.63 M) with profit before overhead, payroll, taxes, and interest of 810 K. | |
| Can Fite Biopharma currently holds about 12.77 M in cash with (8.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. | |
| Can Fite Biopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Bears are Losing Control Over CanFite Biopharma , Heres Why Its a Buy Now |
Can Fite uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Can Fite Biopharma. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Can Fite's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 6th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Can Fite's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.63 M.Market Cap |
|
Project Can Fite's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.76) | (0.80) | |
| Return On Capital Employed | (1.03) | (1.08) | |
| Return On Assets | (0.76) | (0.80) | |
| Return On Equity | (1.22) | (1.28) |
When accessing Can Fite's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Can Fite's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Can Fite's profitability and make more informed investment decisions.
Evaluate Can Fite's management efficiency
Can Fite Biopharma has return on total asset (ROA) of (0.5746) % which means that it has lost $0.5746 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5762) %, meaning that it created substantial loss on money invested by shareholders. Can Fite's management efficiency ratios could be used to measure how well Can Fite manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.8. The current Return On Capital Employed is estimated to decrease to -1.08. At this time, Can Fite's Other Current Assets are most likely to increase significantly in the upcoming years. The Can Fite's current Total Current Assets is estimated to increase to about 10.3 M, while Non Currrent Assets Other are forecasted to increase to (107.7 K).| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.64) | (0.68) | |
| Price Book Value Ratio | 1.52 | 1.45 | |
| Enterprise Value Multiple | (0.64) | (0.68) | |
| Price Fair Value | 1.52 | 1.45 | |
| Enterprise Value | 5.3 M | 5 M |
Leadership effectiveness at Can Fite Biopharma is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 6.4682 | Revenue 667 K | Quarterly Revenue Growth (0.19) | Return On Equity (1.58) |
Can Fite Earnings per Share Projection vs Actual
Can Fite Corporate Management
| Motti Farbstein | Chief Operating and Financial Officer and Principal Accounting Officer | Profile | |
| Sari Fishman | Vice Development | Profile | |
| Ilan Cohn | CoFounder Chairman | Profile | |
| FACP FACR | Clinical Advisor | Profile | |
| MD FACP | Member Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Can Fite. If investors know Can will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Can Fite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Quarterly Revenue Growth (0.19) | Return On Assets (0.57) | Return On Equity (1.58) |
The market value of Can Fite Biopharma is measured differently than its book value, which is the value of Can that is recorded on the company's balance sheet. Investors also form their own opinion of Can Fite's value that differs from its market value or its book value, called intrinsic value, which is Can Fite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Can Fite's market value can be influenced by many factors that don't directly affect Can Fite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Can Fite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Can Fite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Can Fite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.